Integra LifeSciences (IART) Tops Q1 EPS by 12c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Integra LifeSciences (IART) PT Raised to $78 at BTIG
April 28, 2021 1:16 PM EDTBTIG analyst Ryan Zimmerman raised the price target on Integra LifeSciences (NASDAQ: IART) to $78.00 (from $74.00) while maintaining a Buy rating.
The analyst commented, "We maintain our Buy and raise our IART PT to $78 (from $74) following better-than-expected 1Q21 results. Rev. of $360.1M (1.6% Y/Y,... More



